About SRFMX
The Sarofim Equity Fund is an actively managed mutual fund that seeks long-term capital appreciation while prioritizing the preservation of capital. Managed by Fayez Sarofim & Co., the fund primarily invests in the common stocks of large-cap companies, both U.S.-based and international, with market capitalizations exceeding $5 billion at the time of purchase. The fund employs a growth-oriented investment strategy, targeting industry leaders with strong balance sheets, durable competitive advantages, and consistent profitability. Up to 25% of its assets may be allocated to foreign-based firms, including those accessed through American Depositary Receipts.
The portfolio features a concentrated approach, typically holding a relatively small number of high-conviction positions, with a significant portion of assets in its top holdings. Sectors of focus often include technology, healthcare, and consumer discretionary, reflecting the fund's emphasis on growth businesses with global presence. With a low turnover rate and a disciplined buy-and-hold philosophy, the Sarofim Equity Fund aims to reduce trading costs and limit capital gains distributions, making it appealing for long-term investors. This fund plays a prominent role in the large-cap blend category, catering to investors seeking steady equity growth with a moderate risk profile.
Fund Family Sarofim
Category Large Blend
Performance Rating Below Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol SRFMX
Index S&P 500 TR
SRFMX had a total return of 11.22% in the past year, including dividends. Since the fund's
inception, the average annual return has been 10.34%.
